Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities

Monkey Pox Clinical Trial

Official title:

Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05651581
• Other study ID #: Social Protocol
• Status: Completed
• Phase: N/A
• Start date: May 24, 2023
• Est. completion date: August 24, 2023

Study information

• Verified date: October 2023
• Source: University of Minnesota
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study team will create an online module via the REDCap platform. The module will include around 5 videos and several infographics covering the topics of symptoms, transmission, prevention, vaccination, and treatment of the monkeypox virus. Surveys assessing the primary and secondary study endpoints will be given to participants before and after the module. The purpose of the study is to assess the efficacy and acceptability of an educational presentation on monkeypox in a cohort of individuals recruited from Rainbow Health and to secondarily assess participant risk perception, intention to vaccinate, and confidence in public health initiatives.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: August 24, 2023
• Est. primary completion date: August 24, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Individuals who are 18 years and older
• Individuals able to read and write in English

Exclusion Criteria:

• Unable to provide informed consent

Related Conditions & MeSH terms

• Monkey Pox
• Monkeypox

Intervention

Other:
• Online module
online module including around 5 videos and several infographics covering the topics of symptoms transmission, prevention, vaccination, and treatment of the monkeypox virus.

Locations

Country	Name	City	State
United States	University of Minnesota	Minneapolis	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Efficacy of intervention	Efficacy of intervention will be measured by changes in knowledge using a survey	baseline
Primary	Efficacy of intervention	Efficacy of intervention will be measured by changes in knowledge using a survey	immediately after intervention
Primary	Acceptability	Acceptability will be measured by a validated questionnaire based on the Theoretical Framework of Acceptability.	immediately after intervention
Secondary	risk perception	questionnaire	baseline
Secondary	risk perception	questionnaire	immediately after intervention
Secondary	intention to vaccinate	questionnaire	baseline
Secondary	intention to vaccinate	questionnaire	immediately after intervention
Secondary	confidence in public health initiatives	questionnaire	baseline
Secondary	confidence in public health initiatives	questionnaire	immediately after intervention